Health Care

Researchers are testing MDMA, known as ecstasy, to treat depression in people who do not respond to current antidepression drugs.

Engineers and scientists at the University of Texas unveil a diagnosis breakthrough.

ChemoWave helps patients track a wide variety of medical data like symptoms, exercise, water intake and medications.

Health insurer Aetna has hired Ben Wanamaker from Wal-Nart’s health division to lead its joint venture with Apple, according to a source.

The settlement came after an unusual lawsuit by Sanofi, a competitor to Mylan, which alleged anti-competitive tactics.

Goldman Sachs added biotech company Biogen to its Americas Conviction List, citing a ‘blockbuster’ drug.

This could result in a boon in sales for Apple’s health and fitness-tracking smartwatch.

Venture capitalist Jonathan Silverstein is using his problem-solving skills to find a cure for Parkinson’s.

Nurses and home-care aides at Libertana Home Health Care have been experimenting by using Alexa with some elderly clients.

Before the FDA’s approval, sickle cell patients most commonly were treated with a drug that’s also used in chemotherapy.

President Donald Trump is hoping to bring down drug costs and speed the FDA approval process.

The number of insurers applying to sell health plans next year on HealthCare.gov, the federal Obamacare marketplace, is down 38 percent.

Why aren’t more people actively looking for work again with the job market so strong? Part of the answer may be opioid addiction.

The CBO’s estimate of the plan’s effect on the number of uninsured Americans could influence whether Republican senators support it.

While the Senate bill leaves many of the ACA’s provisions in place, it does so with less generous funding.